<DOC>
	<DOCNO>NCT00422994</DOCNO>
	<brief_summary>This study investigate effect severe renal impairment hemodialysis characteristic drug , ropinirole .</brief_summary>
	<brief_title>A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>Inclusion : Patients subject 1879 year old . End stage renal patient consistently receive dialysis minimum 3.5 hour , three time per week , hemodialysis blood flow rate &gt; 200mL/min may eligible enter study . Patients must also systolic blood pressure 100190mmHg diastolic blood pressure &lt; 120mmHg . Healthy subject must systolic blood pressure 100150mmHg . Exclusion : Female subject pregnant and/or breastfeeding must participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>end stage renal impairment</keyword>
	<keyword>tolerability</keyword>
	<keyword>ropinirole</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>hemodialysis</keyword>
</DOC>